Dysbiosis of the Upper Gastrointestinal Tract in Head-and-Neck Cancer Survivors: A Pilot Study Using the Capsule Sponge Device

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Oct 26

PMID 39456621

Authors

Natalia Zeber-Lubecka

Maria Kulecka

Michalina Dabrowska

Anna Kluska

Magdalena Piatkowska

Maryla Helena Turkot

Nastazja Dagny Pilonis

Aisha Yusuf

Karol Nowicki-Osuch

Michal Mikula

Jerzy Ostrowski

Affiliations

Soon will be listed here.

Abstract

Background: A non-endoscopic capsule-sponge device allows sampling the entire length of the esophagus. Here, we compared microbiomes of the oral cavity, esophagus, and gastric corpus collected by oral swab, capsule-sponge device, and endoscopic biopsy, respectively, in patients representing three distinct risk profiles for esophageal squamous cell carcinoma (ESCC).

Methods: The study enrolled 11 patients with esophageal squamous intraepithelial neoplasia, 21 patients after curative treatment for head and neck squamous cell cancer (HNSCC) (HNSCC survivors), and 40 patients with functional dyspeptic (FD) symptoms. Microbial genomic DNA was analyzed using 16S rRNA gene amplicon sequencing.

Results: The Shannon index of the capsule-sponge sample microbiota was significantly higher in FD group than in patients after treatment for HNSCC, and the Chao index of gastric samples differed between HNSCC survivors and FD patients. Analysis of the β-diversity of FD patients, HNSCC, and esophageal squamous intraepithelial neoplasia showed that different genera formed at each location. The abundance of 205, 116, and 9 genera differed between FD patients and HNSCC survivors in the gastric, capsule-sponge, and oral samples, respectively; 33 genera differed between the FD group and patients with esophageal squamous intraepithelial neoplasia in capsule-sponge samples.

Conclusions: The bacterial communities of the upper digestive tract were clustered according to the anatomic site. Despite substantial differences in gastric and esophageal microbiota samples between FD patients and HNSCC survivors, the microbial members and diversity showed small differences between FD patients and those with esophageal squamous intraepithelial neoplasia. It remains unclear whether gastric and esophageal dysbiosis is associated with or is a consequence of treatment for HNSCC.

References

Liu Y, Lin Z, Lin Y, Chen Y, Peng X, He F . Streptococcus and Prevotella are associated with the prognosis of oesophageal squamous cell carcinoma. J Med Microbiol. 2018; 67(8):1058-1068. DOI: 10.1099/jmm.0.000754. View

Zou Q, Feng L, Cai X, Qian Y, Xu L . Esophageal microflora in esophageal diseases. Front Cell Infect Microbiol. 2023; 13:1145791. PMC: 10235470. DOI: 10.3389/fcimb.2023.1145791. View

May M, Abrams J . Emerging Insights into the Esophageal Microbiome. Curr Treat Options Gastroenterol. 2018; 16(1):72-85. PMC: 5843540. DOI: 10.1007/s11938-018-0171-5. View

Maukonen J, Matto J, Suihko M, Saarela M . Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol. 2008; 57(Pt 12):1560-1568. DOI: 10.1099/jmm.0.47352-0. View

Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P . The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012; 41(Database issue):D590-6. PMC: 3531112. DOI: 10.1093/nar/gks1219. View

Andersson A, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L . Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One. 2008; 3(7):e2836. PMC: 2475661. DOI: 10.1371/journal.pone.0002836. View

Hayashi H, Sakamoto M, Benno Y . Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol. 2002; 46(8):535-48. DOI: 10.1111/j.1348-0421.2002.tb02731.x. View

Yang W, Chen C, Jia M, Xing X, Gao L, Tsai H . Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol. 2021; 9:641270. PMC: 7930383. DOI: 10.3389/fcell.2021.641270. View

Nardone G, Compare D, Rocco A . A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol. 2017; 2(4):298-312. DOI: 10.1016/S2468-1253(16)30108-X. View

10.

Liu X, Tong X, Jie Z, Zhu J, Tian L, Sun Q . Sex differences in the oral microbiome, host traits, and their causal relationships. iScience. 2023; 26(1):105839. PMC: 9843272. DOI: 10.1016/j.isci.2022.105839. View

11.

Ma Z, Li W . How and Why Men and Women Differ in Their Microbiomes: Medical Ecology and Network Analyses of the Microgenderome. Adv Sci (Weinh). 2019; 6(23):1902054. PMC: 6891928. DOI: 10.1002/advs.201902054. View

12.

Amir I, Konikoff F, Oppenheim M, Gophna U, Half E . Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2013; 16(9):2905-14. DOI: 10.1111/1462-2920.12285. View

13.

Minalyan A, Gabrielyan L, Scott D, Jacobs J, Pisegna J . The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Curr Gastroenterol Rep. 2017; 19(8):42. PMC: 5621514. DOI: 10.1007/s11894-017-0577-6. View

14.

Ridaura V, Faith J, Rey F, Cheng J, Duncan A, Kau A . Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341(6150):1241214. PMC: 3829625. DOI: 10.1126/science.1241214. View

15.

Zeber-Lubecka N, Kulecka M, Lindner B, Krynicki R, Paziewska A, Nowakowski A . Increased diversity of a cervical microbiome associates with cervical cancer. Front Oncol. 2022; 12:1005537. PMC: 9562559. DOI: 10.3389/fonc.2022.1005537. View

16.

She J, Liu W, Ding X, Guo G, Han J, Shi F . Defining the biogeographical map and potential bacterial translocation of microbiome in human 'surface organs'. Nat Commun. 2024; 15(1):427. PMC: 10781665. DOI: 10.1038/s41467-024-44720-6. View

17.

Snider E, Freedberg D, Abrams J . Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci. 2016; 61(8):2217-2225. PMC: 4945493. DOI: 10.1007/s10620-016-4155-9. View

18.

Ciernikova S, Sevcikova A, Stevurkova V, Mego M . Diet-driven microbiome changes and physical activity in cancer patients. Front Nutr. 2023; 10:1285516. PMC: 10704146. DOI: 10.3389/fnut.2023.1285516. View

19.

Conlon M, Bird A . The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014; 7(1):17-44. PMC: 4303825. DOI: 10.3390/nu7010017. View

20.

Magnano M, Mola P, Machetta G, Maffeis P, Forestiero I, Cavagna R . The nutritional assessment of head and neck cancer patients. Eur Arch Otorhinolaryngol. 2014; 272(12):3793-9. DOI: 10.1007/s00405-014-3462-z. View